Document is current
Any future updates will be listed below
-
Authors
Ainiwan, Yilamujiang
Li, Haomin
Zheng, Yongjia
Wei, Songtao
Peng, Junxiang
Nie, Jing
Mao, Chaofu
Chen, Kunxiang
Chen, Siyuan
Liu, Ningyuan
Li, Can
Chen, Yan
Qu, Shanqiang
Wang, Yunji
Zhou, Mingfeng
Mao, Jian
Mei, Fen
Chen, Jingting
Song, Qiancheng
Qi, Songtao
Pan, Jun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China: A study on the Mechanism of which beta-amyloid regulates the development of adamantinomatous craniopharyngioma by inducing senescence (32400973)
Natural Science Foundation of Guangdong Province,China (2024A1515010060)
National Natural Science Foundation of China: Over-activation of cholesterol metabolism via AMPK-SREBP2 pathway in adamantinomatous craniopharyngioma induces microglial inflammatory response (81972352)
- License Information
-
More Information
Article History
Received: 27 December 2024
Accepted: 22 February 2025
First Online: 3 March 2025
Declarations
:
: (1) Animals: All operations about animals were approved by the Laboratory Animal Center and the Ethics Committee of Southern Medical University and complied with the National Institute of Health Guidelines for the Protection and Use of Laboratory Animals (NFYY-2020-0935). (2) Human subjects: The patients all signed an informed consent form expressing their willingness to allow the use of the excised tumor tissue for scientific research, and the study received approval from the Ethics Committee of Southern Medical University. (3) Clinical Trial: The trial was approved by the Ethics Committee of Nanfang Hospital, Southern Medical University and registered at ClinicalTrial.gov (identifier: NCT00949156). Patients consented to participate in the trial and consented to publication of the outcomes. The work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki).
: All the authors have read the original manuscript and consented to publish it.
: The authors declare no competing interests.
